Optineurin binding to the novel interacting partner Junction plakoglobin prevents muscle atrophy in mice
PLOS Biology · 2026
DOI: 10.1371/journal.pbio.3003581 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2026. Verfasst von Xiao Chen Shi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Animal Genetics, Breeding and Reproduction of Shaanxi Province, College of Animal Science and Technology, Northwest A&F University,…. Hauptthemen laut MEDLINE: Muscular Atrophy, Membrane Transport Proteins, Cell Cycle Proteins, Transcription Factor TFIIIA. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Program for Shaanxi Science & Technology, Postdoctoral Research Foundation of China.
Abstract (Originalsprache)
Skeletal muscle atrophy is a debilitating condition that significantly affects patients’ quality of life and prognosis, yet its underlying mechanisms remain poorly understood. Here, we identify Optineurin (OPTN) as an active regulator for maintenance of muscle homeostasis during muscle atrophy. Knockdown (KD) of Optn induces muscle atrophy, while overexpression of Optn alleviated dexamethasone-induced muscle atrophy in mice. Mechanistically, we for the first time identified Junction plakoglobin (JUP) as a novel interacting partner of OPTN. OPTN alleviates muscle atrophy in a JUP-dependent manner, corroborating JUP as the downstream effector of OPTN-mediated muscle atrophy. RNA-seq analysis revealed that PI3K-AKT pathway is markedly downregulated in Optn -KD muscle, and pharmacological activation of PI3K-AKT pathway effectively rescued muscle atrophy in Optn -KD mice. We further show that OPTN coordinates the interaction between JUP and PI3-Kinase p85 in muscle, promoting activation of the PI3K-AKT pathway. Collectively, our study proposed a conceptual novelty that OPTN-JUP axis mediated activation of the PI3K-AKT pathway during muscle atrophy. These findings offer new insights into the mechanisms of muscle atrophy and suggest potential therapeutic strategies for this condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Animal Genetics, Breeding and Reproduction of Shaanxi Province, College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China.
- Department of Pharmacology, School of Basic Medical Science, Shanxi Medical University, Taiyuan, Shanxi, China.
- Department of Emergency Medicine, the 942nd Hospital of PLA Joint Logistics Support Force, Yinchuan, Ningxia, China.
- Department of Critical Care Medicine, Tangdu Hospital, Air Force Medical University, Xi' an, Shaanxi, China.
ORCID-Profile: Jiang Wei Wu
Förderung
- National Key Research and Development Program of China
- Program for Shaanxi Science & Technology
- Postdoctoral Research Foundation of China
- Natural Science Foundation of Shanxi Province
- Foundation of Shanxi Medical University
Zitieren
APA
Shi, X. C., Zhang, R. X., Feng, J. K., Chen, J. H., Zhang, J. F., Xiao, J. Y., Liu, X. P., Liu, H., Xia, B., Yao, L. N., & Wu, J. W. (2026). Optineurin binding to the novel interacting partner Junction plakoglobin prevents muscle atrophy in mice. PLOS Biology. https://doi.org/10.1371/journal.pbio.3003581
Vancouver
Shi XC, Zhang RX, Feng JK, Chen JH, Zhang JF, Xiao JY, et al. Optineurin binding to the novel interacting partner Junction plakoglobin prevents muscle atrophy in mice. PLOS Biology. 2026. doi:10.1371/journal.pbio.3003581
BibTeX
@article{Shi2026,
author = {Shi, Xiao Chen and Zhang, Rui Xin and Feng, Jun Kai and Chen, Jia Hao and Zhang, Jian Feng and Xiao, Jun Ying and Liu, Xiao Peng and Liu, Huan and Xia, Bo and Yao, Li Nong and Wu, Jiang Wei},
title = {Optineurin binding to the novel interacting partner Junction plakoglobin prevents muscle atrophy in mice},
journal = {PLOS Biology},
year = {2026},
doi = {10.1371/journal.pbio.3003581}
}
EUVIMED